🧫
AGE-mediated HCC induction in animal models with β-catenin signaling
active
experiment
Created: 2026-04-10T22:51:10
By: etl-v1-backfill
Quality:
50%
✓ SciDEX
ID: exp-4910fdf9-d1c3-484d-b9fd-4fd9a5727558
🧫 Experiment Protocol
ValidationHepatocellular carcinomaβ-catenin, AGER1animal models (species not specified)proposed
Animal model experiments investigating how AGEs promote hepatocellular carcinoma development through enhanced ECM viscoelasticity combined with oncogenic β-catenin signaling. The study examined HCC induction in animal models with type 2 diabetes mellitus, focusing on the mechanical properties of the liver ECM and how AGE accumulation affects collagen architecture. The experiments included interventions to inhibit AGE production, reconstitute AGE clearance receptor AGER1, and break AGE-mediated collagen cross-links to assess their effects on viscoelasticity and HCC growth.
PRIMARY OUTCOME
HCC tumor development and growth
EXPECTED OUTCOMES
AGE inhibition and AGER1 reconstitution reduce viscoelasticity and HCC growth
SUCCESS CRITERIA
Reduced tumor burden with AGE pathway interventions
PROTOCOL
AGE manipulation studies, AGER1 reconstitution, collagen cross-link disruption, tumor monitoring
LINKED HYPOTHESES
Source: PMID 38297127 ↗
🧫 Experiment Extras
PATHWAY
Wnt/β-catenin signaling, AGE clearance pathway
MARKET PRICE
$0.50
STATUS
proposed
▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | experiments |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.